This article came out of the Hospital for Special Surgery Journal
What makes BPC-157 remarkable is its systemic reach
Moving from the 0.25 mg starter to 2.4 mg is nearly a tenfold increase, and higher doses produce more weight loss
When stored correctly, it supports extended usability, making it a practical and efficient component in any peptide research workflow
After subcutaneous administration, it circulates systemically, reaches multiple injury locations simultaneously, and modulates the inflammatory environment throughout the body rather than at a single point
Do not exceed recommended servings Pregnant or nursing women, children under 18 and individuals with known medical conditions should consult their physician prior to taking